Daniel E Freedberg1, Hojjat Salmasian2, Bevin Cohen3, Julian A Abrams1, Elaine L Larson3. 1. Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, New York. 2. Department of Biomedical Informatics, New York-Presbyterian Hospital, New York, New York. 3. Department of Epidemiology, Mailman School of Public Health, School of Nursing, Columbia University, New York, New York.
Abstract
OBJECTIVE: To assess whether receipt of antibiotics by prior hospital bed occupants is associated with increased risk for CDI in subsequent patients who occupy the same bed. DESIGN, SETTING, AND PARTICIPANTS: This is a retrospective cohort study of adult patients hospitalized in any 1 of 4 facilities between 2010 and 2015. Patients were excluded if they had recent CDI, developed CDI within 48 hours of admission, had inadequate follow-up time, or if their prior bed occupant was in the bed for less than 24 hours. MAIN OUTCOMES AND MEASURES: The primary exposure was receipt of non-CDI antibiotics by the prior bed occupant and the primary outcome was incident CDI in the subsequent patient to occupy the same bed. Incident CDI was defined as a positive result from a stool polymerase chain reaction for the C difficile toxin B gene followed by treatment for CDI. Demographics, comorbidities, laboratory data, and medication exposures are reported. RESULTS: Among 100 615 pairs of patients who sequentially occupied a given hospital bed, there were 576 pairs (0.57%) in which subsequent patients developed CDI. Receipt of antibiotics in prior patients was significantly associated with incident CDI in subsequent patients (log-rank P < .01). This relationship remained unchanged after adjusting for factors known to influence risk for CDI including receipt of antibiotics by the subsequent patient (adjusted hazard ratio [aHR], 1.22; 95% CI, 1.02-1.45) and also after excluding 1497 patient pairs among whom the prior patients developed CDI (aHR, 1.20; 95% CI, 1.01-1.43). Aside from antibiotics, no other factors related to the prior bed occupants were associated with increased risk for CDI in subsequent patients. CONCLUSIONS AND RELEVANCE: Receipt of antibiotics by prior bed occupants was associated with increased risk for CDI in subsequent patients. Antibiotics can directly affect risk for CDI in patients who do not themselves receive antibiotics.
OBJECTIVE: To assess whether receipt of antibiotics by prior hospital bed occupants is associated with increased risk for CDI in subsequent patients who occupy the same bed. DESIGN, SETTING, AND PARTICIPANTS: This is a retrospective cohort study of adult patients hospitalized in any 1 of 4 facilities between 2010 and 2015. Patients were excluded if they had recent CDI, developed CDI within 48 hours of admission, had inadequate follow-up time, or if their prior bed occupant was in the bed for less than 24 hours. MAIN OUTCOMES AND MEASURES: The primary exposure was receipt of non-CDI antibiotics by the prior bed occupant and the primary outcome was incident CDI in the subsequent patient to occupy the same bed. Incident CDI was defined as a positive result from a stool polymerase chain reaction for the C difficile toxin B gene followed by treatment for CDI. Demographics, comorbidities, laboratory data, and medication exposures are reported. RESULTS: Among 100 615 pairs of patients who sequentially occupied a given hospital bed, there were 576 pairs (0.57%) in which subsequent patients developed CDI. Receipt of antibiotics in prior patients was significantly associated with incident CDI in subsequent patients (log-rank P < .01). This relationship remained unchanged after adjusting for factors known to influence risk for CDI including receipt of antibiotics by the subsequent patient (adjusted hazard ratio [aHR], 1.22; 95% CI, 1.02-1.45) and also after excluding 1497 patient pairs among whom the prior patients developed CDI (aHR, 1.20; 95% CI, 1.01-1.43). Aside from antibiotics, no other factors related to the prior bed occupants were associated with increased risk for CDI in subsequent patients. CONCLUSIONS AND RELEVANCE: Receipt of antibiotics by prior bed occupants was associated with increased risk for CDI in subsequent patients. Antibiotics can directly affect risk for CDI in patients who do not themselves receive antibiotics.
Authors: C Landelle; M Verachten; P Legrand; E Girou; F Barbut; C Brun-Buisson; C Brun Buisson Journal: Infect Control Hosp Epidemiol Date: 2013-11-26 Impact factor: 3.254
Authors: Jacob E Simmering; Linnea A Polgreen; David R Campbell; Joseph E Cavanaugh; Philip M Polgreen Journal: Infect Control Hosp Epidemiol Date: 2015-06-15 Impact factor: 3.254
Authors: Megan K Shaughnessy; Renee L Micielli; Daryl D DePestel; Jennifer Arndt; Cathy L Strachan; Kathy B Welch; Carol E Chenoweth Journal: Infect Control Hosp Epidemiol Date: 2011-03 Impact factor: 3.254
Authors: Philip C Carling; Michael M Parry; Mark E Rupp; John L Po; Brian Dick; Sandra Von Beheren Journal: Infect Control Hosp Epidemiol Date: 2008-11 Impact factor: 3.254
Authors: Erik R Dubberke; Kimberly A Reske; Yan Yan; Margaret A Olsen; L Clifford McDonald; Victoria J Fraser Journal: Clin Infect Dis Date: 2007-12-15 Impact factor: 9.079
Authors: Benjamin Lebwohl; Yael R Nobel; Peter H R Green; Martin J Blaser; Jonas F Ludvigsson Journal: Am J Gastroenterol Date: 2017-10-31 Impact factor: 10.864
Authors: Paula Ferrada; Rachael Callcut; Martin D Zielinski; Brandon Bruns; Daniel Dante Yeh; Tanya L Zakrison; Jonathan P Meizoso; Babak Sarani; Richard D Catalano; Peter Kim; Valerie Plant; Amelia Pasley; Linda A Dultz; Asad J Choudhry; Elliott R Haut Journal: J Trauma Acute Care Surg Date: 2017-07 Impact factor: 3.313
Authors: Sara G Murray; Joanne W L Yim; Rhiannon Croci; Alvin Rajkomar; Gabriela Schmajuk; Raman Khanna; Russell J Cucina Journal: JAMA Intern Med Date: 2017-12-01 Impact factor: 21.873
Authors: Gabriel J Escobar; Jennifer M Baker; Patricia Kipnis; John D Greene; T Christopher Mast; Swati B Gupta; Nicole Cossrow; Vinay Mehta; Vincent Liu; Erik R Dubberke Journal: Infect Control Hosp Epidemiol Date: 2017-08-24 Impact factor: 3.254
Authors: L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox Journal: Clin Infect Dis Date: 2018-03-19 Impact factor: 9.079